Gayatri BioOrganics MD, chairman, board of directors and AGM
BSE: 524564Chemicals & PetrochemicalsSmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹8.00.
- Under BSE's graded surveillance, stage 0, on the list for 22 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹63 Cr2,858th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- Net worth zero or below
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business.
- Net worth zero or below
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- Net worth zero or below
- Volume, BSEVolume. Shares traded on the last trading day.
- 4,056
Gayatri BioOrganics board of directors
At the end of the quarter to Jun 2026, as the company filed it; changes since are in its announcements.Their trades in its shares
- ChairpersonVENKATA SANDEEP KUMARREDDY TIKKAVARAPURelated to the promoter
- Company Secretary and Compliance OfficerHuda Khan
5 directors3 independent1 executive1 non-executive
- VENKATA SANDEEP KUMARREDDY TIKKAVARAPU · ChairpersonNon-executive · joined Dec 1991 · 3 listed boards · 4 committee seats, 1 as chair
- SREEDHARA REDDYKANAPARTHIExecutive · joined Jul 2022 · reappointed Jul 2025 · 1 listed board · 1 committee seat
- VENKATA NARAYANA RAOPALURIIndependent · joined May 2019 · reappointed May 2024 · 85 months as independent · 3 listed boards · 3 as independent · 4 committee seats, 1 as chair
- MEENAKSHI RAMCHAND SACHDEVAIndependent · joined Aug 2022 · reappointed May 2025 · 13 months as independent · 1 listed board · 1 as independent · 1 committee seat
- SRINIVAS IDURIIndependent · joined May 2025 · 13 months as independent · 2 listed boards · 2 as independent · 3 committee seats, 1 as chair
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
2 directors who left
- RAMACHANDRA SESHAPRASAD CHODAVARAPU, left 28 May 2025: Others
- MURALI VITTALA, left 28 May 2025: Others
Committees and meetings
Who sits on each, and how often they met.Board meeting notices and outcomes
Board
- 19 May 20265 of 5 present3 independent · 97 days in between
- 10 Feb 20265 of 5 present3 independent
Audit Committee
Chair VENKATA NARAYANA RAOPALURI
MEENAKSHI RAMCHAND SACHDEVA, SRINIVAS IDURI
- 19 May 20263 of 3 present3 independent · 97 days in between
- 10 Feb 20263 of 3 present3 independent
Nomination and remuneration committee
Chair VENKATA NARAYANA RAOPALURI
MEENAKSHI RAMCHAND SACHDEVA, SRINIVAS IDURI
- 10 Feb 20263 of 3 present3 independent
Stakeholders Relationship Committee
Chair VENKATA SANDEEP KUMARREDDY TIKKAVARAPU
SREEDHARA REDDYKANAPARTHI, VENKATA NARAYANA RAOPALURI
- 10 Feb 20263 of 3 present1 independent
Independent Director Meeting
- 10 Feb 20263 of 3 present3 independent
Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.
Statutory auditor
Named in the results for the quarter to Mar 2026.
- MGR & CO.Peer-review certificate valid to Feb 2029
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Gayatri BioOrganics AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Gayatri BioOrganics share news and announcements
Annual general meeting, 23 Sep 2026
30,610 shareholders on the register on 16 Sep 2026; present: 0 promoters and 53 others; votes counted by Vivek Surana / M/s. Vivek Surana & Associates.The company's voting result (opens in a new tab)
To receive, consider and adopt the Audited Balance Sheet as at March 31, 2026 and the Statement of Profit & Loss and Cash Flow Statement for the year ended on that date together with the Notes attached thereto, along with the Reports of Auditors and Directors thereonMoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 30.23% · promoters 0.00% · institutions 0.00% · other public 38.66%
- To appoint a Director in place of Mr. Sreedhara Reddy Kanaparthi (DIN: 09608890) who retires by rotation and being eligible offers himself for re- appointmentOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 30.23% · promoters 0.00% · institutions 0.00% · other public 38.66%
- APPROVAL FOR CHANGE OF NAME OF THE COMPANY FROM "GAYATRI BIOORGANICS LIMITED" TO "ANANTH BIOORGANICS LIMITEDSpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 30.23% · promoters 0.00% · institutions 0.00% · other public 38.66%
- CHANGE IN DESIGNATION OF MR. SREEDHARA REDDY KANAPARTHI (DIN: 09608890) FROM WHOLE-TIME DIRECTOR TO CHAIRMAN AND MANAGING DIRECTOR OF THE COMPANYSpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 30.23% · promoters 0.00% · institutions 0.00% · other public 38.66%
- ADOPTION OF NEW MEMORANDUM OF ASSOCIATION IN CONFORMITY WITH THE PROVISIONS OF COMPANIES ACT, 2013Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 30.23% · promoters 0.00% · institutions 0.00% · other public 38.66%
- ADOPTION OF NEW ARTICLES OF ASSOCIATION IN CONFORMITY WITH THE PROVISIONS OF COMPANIES ACT, 2013Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 30.23% · promoters 0.00% · institutions 0.00% · other public 38.66%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
How mutual funds voted
Fund houses must disclose how they vote at every meeting of a company they hold.
Mutual fund votes, meeting of 26 Aug 2025, 1 fund house
- 1) Adoption of Audited Financial Statements for the year ended 31st March, 2025 and the Reports of the Directors and Auditors thereon.1 for0 against
- 2) Reappoint Sreedhara Reddy Kanaparthi (DIN: 09608890) as Director, liable to retire by rotation.1 for0 against
- 3) Appoint Vivek Surana & Associates as secretarial auditor for five years from FY26 and fix their remuneration.1 for0 against
- 4) Appoint Srinivas Iduri (DIN: 05192362) as Independent Director for five years from 28 May 2025.1 for0 against
- 5) Appoint Ms. Meenakshi Sachdeva (DIN: 09715062) as Independent Director for five years from 28 May 2025.1 for0 against
- 6) Reappoint Sreedhara Reddy Kanaparthi (DIN: 09608890) as Whole time Director for three years from 14 July 2025 and fix his remuneration as minimum remuneration.1 for0 against
Mutual fund votes, meeting of 31 Aug 2024, 1 fund house
- 1) Adoption of Audited Financial Statements for the year ended 31st March, 2024 and the Reports of the Directors and Auditors thereon.1 for0 against
- 2) Reappoint Venkata Sandeep Kumar Reddy Tikkavarapu (DIN: 00005573) as Director, liable to retire by rotation.1 for0 against
- 3) Reappoint Murali Vittala (DIN: 08688453) as Independent Director for five years from 30 January 2025.1 for0 against
3 earlier meetings
Mutual fund votes, meeting of 28 Sep 2023, 1 fund house
- 1) Adoption of Audited SFinancial Statements for the year ended 31st March, 2023 and the Reports of the Directors and Auditors thereon.1 for0 against
- 2) Reappoint Meenakshi Ramchand Sachdeva (DIN: 09715062) as Director, liable to retire by rotation.1 for0 against
- 3) Appoint MGR & Co. as statutory auditors for five years from the conclusion of 2023 AGM till the conclusion of 2028 AGM and fix their remuneration.1 for0 against
- 4) Reappoint P. V. Narayana Rao (DIN: 07378105) as an Independent Director for five years from 29 May 2024.1 for0 against
- 5) Reappoint and approve continuation of Ramachandra Seshaprasad Chodavarapu (DIN: 08490735) as an Independent Director for five years from 29 May 2024.1 for0 against
Mutual fund votes, meeting of 27 Sep 2022, 1 fund house
- 1) Adoption of Audited Financial Statements for the year ended 31st March, 2022 and the reports of the Directors and Auditors thereon.1 for0 against
- 2) Reappoint T. V. Sandeep Kumar Reddy (DIN: 00005573) as Director, liable to retire by rotation.1 for0 against
- 3) Appoint Ms. Meenakshi Ramchand Sachdeva (DIN: 09715062) as Non-Executive Non-Independent Director from 25 August 2022, liable to retire by rotation.1 for0 against
- 4) Appoint Sreedhara Reddy Kanaparthi (DIN: 09608890) as a Director & Whole-Time Director for three years from 14 July 2022 and fix his remuneration.1 for0 against
Mutual fund votes, meeting of 27 Sep 2021, 1 fund house
- 1) Adoption of Audited Standalone Financial Statements for the year ended 31st March, 2021 and the Reports of the Directors and Auditors thereon.
Against SBI Mutual Fund
- SBI Mutual FundWe have relied upon the auditors’ report, which has not raised concerns on the financial statements but stated that the company has accumulated losses of Rs. 1.1 bn which has completely eroded its net worth. As per the auditor, the financial statements have been prepared on a going concern basis based on a comfort letter received from promoters of the company. However, we note that the despite no concerns being raised, we believe the significant erosion of Networth is a serious cause of concern. Further, the auditors have raised concerns over the company’s internal financial control, stating that they did not have sufficient audit evidence to provide a basis for their opinion.
0 for1 against - 2) Re-appoint Mr. T. V. Sandeep Kumar Reddy as a Director.
Against SBI Mutual Fund
- SBI Mutual FundT. V. Sandeep Kumar Reddy, 54, is one of the company’s promoters and is Managing Director of Gayatri Projects Limited. He has been on the board since December 1991, attended all board meetings in FY21 and retires by rotation. However, the auditor concerns and poor performance reflected in the accumulated losses and erosion of networth, which in turn has resulted in a significant erosion in shareholder wealth. Require the change of board. Having the promoters on the board may impede the directors’ ability to take hard decisions.
0 for1 against
Each fund house counted once, from its own disclosure; the reasons are its own words.
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The board is made up as the listing rules require
- Yes
- The board has a regular chairperson
- Yes
- The company has a risk management committee
- No
- The chair is related to the managing director
- No
- The filing has a part on fines and penalties
- No
- The filing has a part on tax disputes
- No
- There was a cyber security incident in the quarter
- No
The company's own answers in its filing.